Abstract
Background
Marginal ulcer (MU) is an uncommon but significant complication following one-anastomosis gastric bypass (OAGB). Our study aims to understand the incidence rates, risk factors, and management of MU following OAGB.
Methods
MEDLINE, Scopus, and Cochrane Library databases were examined to identify all studies on OAGB where authors had reported on MU. Data were collected on basic demographics, incidence rates, risk factors, and management of this condition.
Results
Thirty-two studies involving 8868 patients were analysed. The mean age and body mass index (BMI) of patients in these studies were 40.9 ± 4.5 years and 47.6 ± 5.6 kg/m2, respectively. Among the patient cohort, approximately 72% were female, and 20.6% had preoperative gastroesophageal reflux disease (GERD). The authors described prescribing proton-pump inhibitors (PPI) prophylaxis to 14.1% of patients after surgery. Two hundred twenty-eight patients were reported to have MU. The incidence of MU was 2.59% (95% CI 1.89–3.52), of which 53 patients presented within 12 months, 24 patients presented after 31 months, and five patients after 6 years. One hundred forty-six patients did not have presentation time documented. Sixty-five patients were described to have MU diagnosed on endoscopy, of which 54 were symptomatic and 11 were asymptomatic. The authors were, however, not specific on the choice of investigation for the remaining 163 patients. Of patients, 89.7% were treated conservatively with PPIs, whilst 10.3% had surgery to treat MU.
Conclusions
Marginal ulcer is an uncommon complication following OAGB. The majority of patients are treated conservatively with PPIs. Larger, well-designed studies reporting on risk factors, investigation, and management of MU following OAGB are warranted.
Graphical Abstract
Similar content being viewed by others
References
Baker C. Obesity statistics. commonslibrary.parliament.uk, [online] 1(3336). 2023. Available at: https://commonslibrary.parliament.uk/research-briefings/sn03336/. Accessed 31 July 2023.
Small P, Md R, Kamal Mahawar F, Frcsed M, Walton P, Frcp M, Kinsman R. The United Kingdom National Bariatric Surgery Registry Third Registry Report 2020 on behalf of the NBSR Data Committee. 2020. Available at: https://e-dendrite.com/Publishing/Reports/Bariatric/NBSR2020.pdf. Accessed 31 July 2023.
Schauer P, Ikramuddin S. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.
Angrisani L, Santonicola A, Lovino P, Ramos A, Shikora S, Kow L. Bariatric surgery survey 2018: similarities and disparities among the 5 IFSO chapters. Obes Surg. 2018;2021(31):1937–48.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.
Peterko AC, Mazul Sunko B, Mirosevie G, et al. Combined sleeve gastrectomy and mini gastric bypass in a new bariatric procedure of mini gastric bypass and proximal sleeve gastrectomy. Acta Clin Croat. 2013;52:316–20.
Franco JV, Ruiz PA, Palermo M, et al. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg. 2011;21:1458–68.
Wharton S, Serodio KJ, Kuk JL, Sivapalan N, Craik A, Arts MA. Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity. Clin Obes. 2016;6(2):154–60.
Martinino A, Bhandari M, Abouelazayem M, Abdellatif A, Koshy RM, Mahawar K. Perforated marginal ulcer after gastric bypass for obesity: a systematic review. Surg Obes Related Dis. 2022;18(9):1168–75.
Magouliotis DE, Tasiopoulou VS, Tzovaras G. One anastomosis gastric bypass versus Roux-en-Y gastric bypass for morbid obesity: an updated meta-analysis. Obes Surg. 2019;29:2721–30.
Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should surveillance endoscopy be routine after one anastomosis gastric bypass to detect marginal ulcers: initial outcomes in a tertiary referral centre. Obes Surg. 2020;30:4974–80.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
Jadad AR et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials. 1996;17:1–12.
GA Wells, B Shea, D O’Connell, J Peterson, V Welch, M Losos, P Tugwell. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 31 July 2023.
R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. <https://www.R-project.org/>. Accessed 31 July 2023.
Schwarzer G. General Package for Meta-Analysis [R package meta version 4.18-0]. 2021.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986;7(177e):188.
Miller KA, Radauer M, Buchwald JN, McGlennon TW, Ardelt-Gattinger E. 5-year results of banded one-anastomosis gastric bypass: a pilot study in super-obese patients. Obes Surg. 2020;30(11):4307–14. https://doi.org/10.1007/s11695-020-04824-6.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses-first study from Indian subcontinent. Obes Surg. 2014;24(9):1430–5. https://doi.org/10.1007/s11695-014-1220-3.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. 2016;26(5):926–32. https://doi.org/10.1007/s11695-015-1869-2.
Campanelli M, Bianciardi E, Benavoli D, Bagaglini G, Lisi G, Gentileschi P. Laparoscopic banded one anastomosis gastric bypass: a single-center series. J Obes. 2022;29(2022):4942052. https://doi.org/10.1155/2022/4942052.
Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005 Jul;242(1):20–8. https://doi.org/10.1097/01.sla.0000167762.46568.98.
Kansou G, Lechaux D, Delarue J, Badic B, Le Gall M, Guillerm S, Bail JP, Thereaux J. Laparoscopic sleeve gastrectomy versus laparoscopic mini gastric bypass: one year outcomes. Int J Surg. 2016;33(Pt A):18–22. https://doi.org/10.1016/j.ijsu.2016.07.051.
Noun R, Riachi E, Zeidan S, Abboud B, Chalhoub V, Yazigi A. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17(11):1482–6. https://doi.org/10.1007/s11695-008-9426-x.
Sumer A, Mahawar K, Aktokmakyan TV, Savas OA, Peksen C, Barbaros U, Mercan S. Bridged one-anastomosis gastric bypass: technique and preliminary results. Surg Today. 2021;51(8):1371–8. https://doi.org/10.1007/s00595-021-02264-y.
Rheinwalt KP, Plamper A, Rückbeil MV, Kroh A, Neumann UP, Ulmer TF. One anastomosis gastric bypass-mini-gastric bypass (OAGB-MGB) versus Roux-en-Y gastric bypass (RYGB)-a mid-term cohort study with 612 patients. Obes Surg. 2020;30(4):1230–40. https://doi.org/10.1007/s11695-019-04250-3.
Charalampos T, Maria N, Vrakopoulou VGZ, Tania T, Raptis D, George Z, Emmanouil L, Konstantinos A. Tailored one anastomosis gastric bypass: 3-year outcomes of 94 patients. Obes Surg. 2019;29(2):542–51. https://doi.org/10.1007/s11695-018-3572-6.
Elkerkary MA, Adly OA, Elhadary MKE, et al. Comparison between the effect of laparoscopic sleeve gastrectomy and laparoscopic mini-gastric bypass on type 2 diabetes mellitus in obese patients: a prospective study. World J Lap Surg. 2021;14(2):131–5.
Olmi S, Oldani A, Cesana G, Ciccarese F, Uccelli M, De Carli SM, Villa R, David G, Giorgi R, Zanoni AAG. Laparoscopic one anastomosis gastric bypass versus laparoscopic one anastomosis gastric bypass with Braun anastomosis: what’s better? J Laparoendosc Adv Surg Tech A. 2019;29(11):1469–74. https://doi.org/10.1089/lap.2019.0218.
Winstanley J, Ahmed S, Courtney M, Sam M, Mahawar K. One anastomosis gastric bypass in patients with gastrooesophageal reflux disease and/or hiatus hernia. Obes Surg. 2021;31(4):1449–54. https://doi.org/10.1007/s11695-020-05149-0.
Mari A, Khoury T, Daud G, Lubany A, Safadi M, Sbeit W, Pellicano R, Mahamid M. The yield, effectiveness and safety of gastroscopy in management of early postbariatric upper gastrointestinal pain. Minerva Chir. 2020;75(3):164–8. https://doi.org/10.23736/S0026-4733.20.08282-6.
Tasdighi E, Mousapour P, Khalaj A, Sadeghian Y, Mahdavi M, Valizadeh M, Barzin M. Comparison of mid-term effectiveness and safety of one-anastomosis gastric bypass and sleeve gastrectomy in patients with super obesity (BMI ≥ 50 kg/m2). Surg Today. 2022;52(5):854–62. https://doi.org/10.1007/s00595-021-02387-2.
Bhandari M, Nautiyal HK, Kosta S, Mathur W, Fobi M. Comparison of one anastomosis gastric bypass (OAGB) and Roux-en-Y gastric bypass (RYGB) for treatment of obesity: a five-year study. Surg Obes Related Dis. 2019; https://doi.org/10.1016/j.soard.2019.05.025.
Liagre A, Martini F, Kassir R, Juglard G, Hamid C, Boudrie H, Van Haverbeke O, Antolino L, Debs T, Petrucciani N. Is one anastomosis gastric bypass with a biliopancreatic limb of 150 cm effective in the treatment of people with severe obesity with BMI > 50? Obes Surg. 2021;31(9):3966–74. https://doi.org/10.1007/s11695-021-05499-3.
Piazza L, Ferrara F, Leanza S, Coco D, Sarvà S, Bellia A, Di Stefano C, Basile F, Biondi A. Laparoscopic mini-gastric bypass: short-term single-institute experience. Updates Surg. 2011;63(4):239–42. https://doi.org/10.1007/s13304-011-0119-y.
Shivakumar S, Tantia O, Goyal G, Chaudhuri T, Khanna S, Ahuja A, Poddar A, Majumdar K. LSG vs MGB-OAGB-3 year follow-up data: a randomised control trial. Obes Surg. 2018;28(9):2820–8. https://doi.org/10.1007/s11695-018-3255-3.
ElAbd R, AlMutairi R, Alhaj A, AlKhayat H, Jamal MH. One-anastomosis gastric bypass as a primary bariatric surgery: initial experience and short-term outcomes. Bariatric Surg Prac Patient Care. 2021:220–5. https://doi.org/10.1089/bari.2020.0063.
Pizza F, D'Antonio D, Lucido FS, Tolone S, Dell'Isola C, Gambardella C. Postoperative Clinical-endoscopic follow-up for GERD and gastritis after one anastomosis gastric bypass for morbid obesity: how, when, and why. Obes Surg. 2020;30(11):4391–400. https://doi.org/10.1007/s11695-020-04805-9.
Pizza F, D'Antonio D, Lucido FS, Tolone S, Del Genio G, Dell'Isola C, Docimo L, Gambardella C. The Role of ursodeoxycholic acid (UDCA) in cholelithiasis management after one anastomosis gastric bypass (OAGB) for morbid obesity: results of a monocentric randomized controlled triaL. Obes Surg. 2020;30(11):4315–24. https://doi.org/10.1007/s11695-020-04801-z.
Saarinen T, Pietiläinen KH, Loimaala A, Ihalainen T, Sammalkorpi H, Penttilä A, Juuti A. Bile reflux is a common finding in the gastric pouch after one anastomosis gastric bypass. Obes Surg. 2020;30(3):875–81. https://doi.org/10.1007/s11695-019-04353-x.
Slagter N, Hopman J, Altenburg AG, de Heide LJM, Jutte EH, Kaijser MA, Damen SL, van Beek AP, Emous M. Applying an anti-reflux suture in the one anastomosis gastric bypass to prevent biliary reflux: a long-term observational study. Obes Surg. 2021;31(5):2144–52. https://doi.org/10.1007/s11695-021-05238-8.
Meydan C, Raziel A, Sakran N, Gottfried V, Goitein D. Single anastomosis gastric bypass-comparative short-term outcome study of conversional and primary procedures. Obes Surg. 2017;27(2):432–8. https://doi.org/10.1007/s11695-016-2336-4.
Schmitz SM, Alizai PH, Kroh A, Schipper S, Brozat JF, Plamper A, Neumann UP, Rheinwalt K, Ulmer TF. Clinical outcomes after one anastomosis gastric bypass versus sleeve gastrectomy in super-super-obese patients. Surg Endosc. 2022;36(6):4401–7. https://doi.org/10.1007/s00464-021-08790-7.
Szymański M, Marek I, Wilczyński M, Janczy A, Bigda J, Kaska Ł, Proczko-Stepaniak M. Evaluation of esophageal pathology in a group of patients 2 years after one-anastomosis gastric bypass (OAGB) - Cohort study. Obes Res Clin Pract. 2022;16(1):82–6. https://doi.org/10.1016/j.orcp.2021.12.001.
Musella M, Susa A, Greco F, De Luca M, Manno E, Di Stefano C, Milone M, Bonfanti R, Segato G, Antonino A, Piazza L. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63. https://doi.org/10.1007/s00464-013-3141-y.
Markopoulos G, Skroubis G, Kalfarentzos F, Kehagias I. Comparison of one anastomosis gastric bypass versus standard Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion, in a case-matched, non-superobese population: 6 years of follow-up. Prz Gastroenterol. 2022;17(2):152–61. https://doi.org/10.5114/pg.2021.108453.
Mustafa A, Rizkallah NNH, Samuel N, Balupuri S. Laparoscopic Roux-En-Y gastric bypass versus one anastomosis (loop) gastric bypass for obesity: a prospective comparative study of weight loss and complications. Ann Med Surg (Lond). 2020 18;55:143-147. 10.1016/j.amsu.2020.04.040. Erratum in: Ann Med Surg (Lond). 2020 Nov 18;60:701.
Giannopoulos S, Athanasiadis DI, Clapp B, Lyo V, Ghanem O, Puzziferri N, Stefanidis D. American Society for Metabolic and Bariatric Surgery Research Committee. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: a national survey of surgeon practices. Surg Obes Relat Dis. 2023;19(4):303–8. https://doi.org/10.1016/j.soard.2022.10.002.
Ying VW, Kim SH, Khan KJ, et al. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies. Surg Endosc. 2015;29(5):1018–23. https://doi.org/10.1007/s00464-014-3794-1.
Mahawar KK, Parmar C, Graham Y. Procedure and patient selection in bariatric and metabolic surgery. Minerva Chir. 2019;74(5):407–13. https://doi.org/10.23736/S0026-4733.19.08121-5.
Brown WA, Johari Halim Shah Y, Balalis G, Bashir A, Ramos A, Kow L, Herrera M, Shikora S, Campos GM, Himpens J, Higa K. IFSO position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30(8):3135–53. https://doi.org/10.1007/s11695-020-04720-z.
Bertrand T, Rives-Lange C, Jannot AS, et al. 150-cm versus 200-cm biliopancreatic limb one-anastomosis gastric bypass: propensity score-matched analysis. Obes Surg. 2022;32(9):2839–45. https://doi.org/10.1007/s11695-022-06203-9.
Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25(6):951–8. https://doi.org/10.1007/s11695-014-1552-z.
Wilson JA, Romagnuolo J, Byrne TK, Morgan K, Wilson FA. Predictors of endoscopic findings after Roux-en-Y gastric bypass. Am J Gastroenterol. 2006;101(10):2194–9. https://doi.org/10.1111/j.1572-0241.2006.00770.x.
Beran A, Shaear M, Al-Mudares S, et al. Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis [published online ahead of print, 2023 Feb 16]. J Gastrointest Surg. 2023; https://doi.org/10.1007/s11605-023-05619-7.
Bhayani NH, Oyetunji TA, Chang DC, Cornwell 3rd EE, Ortega G, Fullum TM. Predictors of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. J Surg Res. 2012;177(2):224–7. https://doi.org/10.1016/j.jss.2012.06.003.
Acknowledgements
The authors thank Hugh Hanchard for helping with the initial literature search.
Author information
Authors and Affiliations
Contributions
Study conceptualisation: K.M., S.L., S.S.
Data analysis: S.L., C.V.
Writing the manuscript and approving the finalised manuscript: S.L., S.S., C.V., K.M.
Corresponding author
Ethics declarations
Ethical Approval
Formal consent is not required for this type of study.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points
• The overall estimated incidence of MU after OAGB was 2.59%.
• Approximately 65% of patients presented within the first 12 months after surgery.
• The majority of patients (89.7%) are treated conservatively with PPIs.
Appendix Search strategy
Appendix Search strategy
Ovid MEDLINE(R) ALL <1946 to August 10, 2022>
1 | exp *Peptic Ulcer/ | 61,705 |
2 | (marginal ulcer or marginal ulceration or marginal ulcers).mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 490 |
3 | stomal ulceration.mp. | 39 |
4 | (stomal ulcers or stomal ulcer).mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 156 |
5 | 2 or 3 or 4 | 671 |
6 | (gastric adj bypass).mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 16,341 |
7 | (bariatric adj bypass).mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 26 |
8 | exp *Gastric Bypass/ | 9793 |
9 | 6 or 7 or 8 | 16,354 |
10 | 5 and 9 | 308 |
11 | 10 | 308 |
12 | limit 11 to (English language and humans and yr=“2015–Current”) | 128 |
13 | proton pump inhibitor.mp. or exp *Proton Pump Inhibitors/ | 17,160 |
14 | proton pump inhibitors.mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 17,792 |
15 | 13 or 14 | 24,634 |
16 | 9 and 15 | 149 |
17 | prophylaxis.mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 12,0005 |
18 | prophylactic.mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 87,767 |
19 | 17 or 18 | 19,1174 |
20 | 16 and 19 | 17 |
21 | 10 | 308 |
22 | limit 21 to (human and English language and exclude medline journals and yr=“2019–Current”) | 65 |
23 | 20 not 10 | 4 |
24 | 23 | 4 |
25 | limit 24 to (English language and exclude medline journals) | 4 |
26 | incidence.mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 97,3337 |
27 | 9 and 26 | 1487 |
28 | (ulcer or ulcers or ulceration).mp. [mp=title, book title, abstract, original title, name of substance word, subject heading word, floating sub-heading word, keyword heading word, organism supplementary concept word, protocol supplementary concept word, rare disease supplementary concept word, unique identifier, synonyms] | 21,0204 |
29 | 27 and 28 | 137 |
30 | 29 not 10 | 45 |
31 | 30 | 45 |
32 | limit 31 to (English language and humans and yr=“2019–Current”) | 6 |
33 | 9 and 15 and 19 and 28 | 15 |
34 | 33 not 30 | 15 |
35 | 33 not 20 | 0 |
Scopus
“mason’s loop” OR “mini-gastric bypass” OR “mini-gastric bypass” OR “single anastomosis gastric bypass” OR “single-anastomosis gastric bypass” OR “single anastomosis (mini-) gastric bypass” OR “one anastomosis (mini-) gastric bypass” OR “one anastomosis gastric bypass” OR “one-anastomosis gastric bypass” OR “omega gastric bypass” OR “omega-loop bypass” OR “omega loop bypass” AND “Peptic ulcer disease” OR “marginal ulceration” OR “anastomotic ulcer” OR “ischemic ulcer” OR “ulcers” OR “ulcera*”
Cochrane
mason’s loop OR mini-gastric bypass OR mini-gastric bypass OR single anastomosis gastric bypass OR single-anastomosis gastric bypass OR single anastomosis (mini-) gastric bypass OR one anastomosis (mini-) gastric bypass OR one anastomosis gastric bypass OR one-anastomosis gastric bypass OR omega gastric bypass OR omega-loop bypass OR omega loop bypass in Title Abstract Keyword AND Peptic ulcer disease OR marginal ulceration OR anastomotic ulcer OR ischemic ulcer OR ulcers OR ulcera* in Title Abstract Keyword
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, S., Supparamaniam, S., Varghese, C. et al. Marginal Ulcers Following One-Anastomosis Gastric Bypass: a Systematic Review and Meta-analysis. OBES SURG 33, 2884–2897 (2023). https://doi.org/10.1007/s11695-023-06762-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-023-06762-5